BHEL Signs Agreement with Hystar AS, Norway for PEM Electrolyser Systems for Green Hydrogen Projects

Bharat Heavy Electricals Ltd. (BHEL) has entered into a strategic partnership with Norway-based Hystar AS to enable phased indigenisation and local manufacturing of Proton Exchange Membrane (PEM) electrolyser systems for green hydrogen projects in India, as per the exchange filings. 

BHEL Expands Green Hydrogen Electrolyser Capabilities 

The collaboration will enable BHEL to progressively localise the manufacturing of PEM electrolyser systems in India. The partnership is also expected to strengthen BHEL's capabilities in executing green hydrogen projects across the country. 

Partnership Expands Electrolyser Technology Portfolio 

BHEL had earlier entered into a strategic tie-up with thyssenkrupp nucera India for alkaline electrolyser systems.  

With the latest collaboration with Hystar for PEM technology, BHEL said it is among the few Indian companies capable of offering both alkaline and PEM electrolyser solutions. 

Focus on Local Manufacturing 

The agreement is aimed at supporting phased indigenisation, allowing BHEL to build domestic manufacturing capabilities for PEM electrolysers. This could strengthen the company's role in India's developing green hydrogen ecosystem. 

Read More: IPO Alert: Muthoot Fincorp Files DRHP with SEBI to Raise Funds! 

BHEL Share Price Performance 

As of August 13, 2026, at 3:30 PM, BHEL share price closed at ₹420.00 per share, a 0.19% down from the previous closing price. 

Conclusion 

BHEL's partnership with Hystar strengthens its position in India's emerging green hydrogen market by adding PEM electrolyser technology to its existing alkaline electrolyser capabilities. The focus on phased localisation and domestic manufacturing also supports the company's participation in India's green hydrogen development. 

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.